AI assistant
Sending…
ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2025
Apr 3, 2025
32464_dirs_2025-04-02_01400df3-dbb1-40a2-9476-b7d3ede08599.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2025-03-31
Reporting Person: Thomas Steffen (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | Stock Option (Right to Buy) | $8.58 | A | 50000 | Acquired | 2035-03-31 | Common Stock (50000) | Direct |
Footnotes
F1: The option vests in three equal annual installments beginning on March 31, 2026
More from ANAVEX LIFE SCIENCES CORP.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Feb 25
Interim / Quarterly Report
2026
Feb 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Annual Report
2025
Nov 25
Regulatory Filings
2025
Nov 25